Prevention of recurrent calcium stone formation with potassium citrate therapy in patients with distal renal tubular acidosis

G. M. Preminger, K. Sakhaee, C. Skurla, C. Y C Pak

Research output: Contribution to journalArticle

139 Scopus citations

Abstract

Distal renal tubular acidosis is a common cause of intractable calcium nephrolithiasis. We examined the effect of oral potassium citrate therapy in 9 patients with incomplete distal renal tubular acidosis diagnosed on the basis of an abnormal response to an oral ammonium chloride load. Patients were studied during a control phase and after 3 months of potassium citrate treatment (60 to 80 mEq. daily). Potassium citrate caused a significant increase in urinary pH and urinary citrate, and a decrease in urinary calcium. The urinary relative saturation ratio of calcium oxalate significantly decreased during treatment, while that of brushite did not change. Potassium citrate also was shown to inhibit new stone formation. During a mean treatment period of 34 months none of the 9 patients had new stones, although 39.3 plus or minus 79.7 (standard deviation) stones per patient formed during the 3 years preceding treatment. The results support the potential clinical advantage of potassium citrate therapy in patients with distal renal tubular acidosis and recurrent calcium nephrolithiasis.

Original languageEnglish (US)
Pages (from-to)20-23
Number of pages4
JournalJournal of Urology
Volume134
Issue number1
DOIs
StatePublished - Jan 1 1985

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'Prevention of recurrent calcium stone formation with potassium citrate therapy in patients with distal renal tubular acidosis'. Together they form a unique fingerprint.

  • Cite this